Professor of Psychiatry, McLean Hospital
Neurology
Dr. Roger D. Weiss, MD
|
|
Give Review
Roger Weiss practices Neurology. He researched medicine at Tufts University School of Medicine. Tufts University School of Medicine is ranked 49/52 in Research/PrimaryCare. He has 2 awards "America's Top Doctors" and "Boston Magazine". Roger D. Weiss is also a published physician. He has 100 publication published. The most recent publication is: A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.
Publications
- A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.
- Short term health-related quality of life improvement during opioid agonist treatment.
- Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen.
- Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
- Health-related quality of life among prescription opioid-dependent patients: Results from a multi-site study.
- Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population.
- Denial of urinalysis-confirmed opioid use in prescription opioid dependence.
- Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients.
- Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series.
- An electronic screen for triaging adolescent substance use by risk levels.
- Opioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: A discrete survival and growth mixture model.
- Prescription drug abuse: from epidemiology to public policy.
- The multi-site prescription opioid addiction treatment study: 18-month outcomes.
- Achieving Cannabis Cessation - Evaluating N-acetylcysteine Treatment (ACCENT): Design and implementation of a multi-site, randomized controlled study in the National I...
- Reasons for opioid use among patients with dependence on prescription opioids: The role of chronic pain.
- Who benefits from additional drug counseling among prescription opioid-dependent patients receiving buprenorphine-naloxone and standard medical management?
- Behavioural treatment combined with buprenorphine does not reduce opioid use compared with buprenorphine alone.
- Cue-induced craving in dependence upon prescription opioids and heroin.
- Readability of self-report alcohol misuse measures.
- Changes in sleep disruption in the treatment of co-occurring posttraumatic stress disorder and substance use disorders.
- Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence.
- Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.
- The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.
- Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.
- Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: a pilot study.
- Association of cannabis use with opioid outcomes among opioid-dependent youth.
- Positive affect and stress reactivity in alcohol-dependent outpatients.
- Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: A comparative longitudinal study.
- Gender differences in a clinical trial for prescription opioid dependence.
- Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.
- Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.
- Diagnosing and treating opioid dependence.
- Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure.
- Craving of Prescription Opioids in Patients With Chronic Pain: A Longitudinal Outcomes Trial.
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial.
- GABRG1 and GABRA2 Variation Associated with Alcohol Dependence in African Americans.
- Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.
- Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations.
- Implementing an Adapted Version of the Job Seekers' Workshop in a Residential Program for Patients with Substance Use Disorders.
- Acceptability of drug testing in an outpatient substance abuse program for adolescents.
- The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.
- Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled t...
- Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.
- The Relationship of Manic Episodes and Drug Abuse to Sexual Risk Behavior in Patients with Co-Occurring Bipolar and Substance Use Disorders: a 15-Month Prospective Ana...
- HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.
- Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network.
- Confirmation and generalization of an alcohol-dependence locus on chromosome 10q.
- A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview.
- A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology.
- Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.
- A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.
- Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations.
- Rapid cognitive screening of patients with substance use disorders.
- Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies.
- HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.
- The duration of inpatient admission predicts cognitive functioning at discharge in patients with bipolar disorder.
- Association of variants in MANEA with cocaine-related behaviors.
- Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
- Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders.
- Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10.
- Cognitive functioning in bipolar and co-occurring substance use disorders: a missing piece of the puzzle.
- Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study.
- An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.
- Response: providing relief, avoiding euphoria.
- Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome.
- Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
- Identifying and diagnosing co-occurring disorders.
- Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities.
- Focus on alcohol & drug abuse: ensuring validity in urine drug testing.
- Chronic pain severity in opioid-dependent patients.
- Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP).
- A review of brief medication-adherence instruments used in patients with schizophrenia and bipolar disorder.
- Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.
- Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing.
- A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.
- The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability.
- The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder.
- Combining psychosocial treatment with pharmacotherapy for alcohol dependence.
- Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial.
- Self-harm and suicidal behavior in women with comorbid PTSD and substance dependence.
- Addressing substance abuse in health care settings.
- Seeking Safety plus Exposure Therapy: an outcome study on dual diagnosis men.
- Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
- Readability of patient handout materials in a nationwide sample of alcohol and drug abuse treatment programs.
- Use of a "psychotherapy with no pills" treatment condition as part of a combined pharmacotherapy-psychotherapy research study of alcohol dependence.
- A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence.
- Treating patients with bipolar disorder and substance dependence: lessons learned.
- Group therapy for substance use disorders: what do we know?
- Treatment utilization by women with PTSD and substance dependence.
- Psychosocial treatments for cocaine dependence.
- Mediators of outcome of psychosocial treatments for cocaine dependence.
- Limiting inpatient substance use treatment: what are the consequences?
- The relationship between educational attainment and relapse among alcohol-dependent men and women: a prospective study.
- The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use.
- Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
- What general psychiatrists ask addiction psychiatrists: a review of 381 substance abuse consultations in a psychiatric hospital.
- Medical morbidity, mental illness, and substance use disorders.
- Alcohol use disorders in pregnancy.
- Clinician beliefs and attitudes about buprenorphine/naloxone diversion.
Schools
Tufts University
McLean Hospital
Doctors Specialties
- Addiction Psychiatry
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
Education
-
Tufts University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas R. Sciascia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Wines Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Levin, MD |
|
|
Dr. Mark D. Green, MD |
|
|
Dr. Evan D. Murray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyun Duk Yang, MD |
|
|
Dr. Sanchit Maruti, MD |
|
|
Dr. Sumita G. Manwani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgar A. Buttner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sandra Lobo, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michele L. Masi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Liza Yessayan, MD
This Doctor is OpenDoctor Recommended.
|